Professor Constantin Coussios is the Director of the Oxford Institute of Biomedical Engineering. He received his BA, MEng and PhD in Engineering from the University of Cambridge and was elected to the first statutory chair in Biomedical Engineering at the University of Oxford in 2011, with special responsibility for drug delivery and non-invasive therapies.
In 2014, he co-founded OxSonics Ltd, which is developing a new generation of ultrasound-based medical devices for cavitation-enhanced drug delivery and minimally invasive surgery.
The author of over 100 publications and 16 patents, he was awarded the 2017 RAEng Silver Medal for his contributions to organ preservation and therapeutic ultrasound.
drug delivery, ultrasound, cavitation, nanotechnology, tissue fractionation